Weibo Corp vs State Street SPDR S&P Biotech ETF — how do they compare? Weibo Corp trades at $8 (market cap $1.95B), while State Street SPDR S&P Biotech ETF trades at $154.43. The key difference: Weibo Corp pays a 7.63% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Weibo Corp nearer its low. Which is the better fit depends on your goals.
| WB | XBI | |
|---|---|---|
Market Cap | $1.95B | — |
Sector | Media | Broad Market / Factor |
52-Week High | $12.83 | $164.28 |
52-Week Low | $7.20 | $85.16 |
Enterprise Value | $1.22B | — |
Dividend Yield | 7.63% | — |
Signals from Pluang's Aura AI — not financial advice
Weibo (WB) trades at $8.00, up 3.23% today, with a bullish technical signal from moving averages. The stock shows strong profitability with a 21.15% net income margin and trades at discounted valuations including a P/E of 5.59 and P/B of 0.51. Recent earnings missed expectations for three consecutive quarters, but the company maintains robust cash flow generation and a solid balance sheet with $2.35 billion in cash.
The outlook is mixed: deep value metrics and analyst buy ratings (45%) support upside potential, but competitive pressures and recent earnings misses pose risks. The stock's 8% dividend yield provides income support while investors await improved execution and AI monetization opportunities to drive growth.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →